Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × Radiofrequency Ablation × 1 year × Clear all

Sponsor

Conditions

Thyroid Nodule 4 Thyroid Neoplasms 3 Pain 2 Agnosia 2 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Neuroma 1 Neuralgia 1 Neoplasm Metastasis 1 Myoma 1 Multiple Advanced Tumors After PD-1 Therapy Failure 1 Multi-organ Metastatic Colorectal Cancer 1 Menorrhagia 1 Lymphatic Metastasis 1 Leiomyoma 1 Klatskin Tumor 1 Hypesthesia 1 Hyperthyroidism 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Medullary 1 Breast Neoplasms 1 Breast Cancer Female 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Adenoma, Islet Cell 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

tremelimumab 4 lenvatinib 3 durvalumab 3 Nivolumab 3 Ipilimumab 2 spartalizumab 1 relatlimab 1 poly ICLC 1 pembrolizumab 1 balstilimab 1 Radiotherapy 1 Peptides 1 Opdualag 1 Capecitabine 1 Bevacizumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡